donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 00399 INNOVATIVE PHAR > Key Indicators
00399 INNOVATIVE PHAR
0.1850.0000.00%
YOY
Do not show
Hide blank lines
(FY)2022/03/31(Q6)2021/09/30(FY)2021/03/31(Q6)2020/09/30
Per Share IndicaTor
Operating Cash Flow Per Share
50.67% -0.0084 -57.74% -0.0104 30.97% -0.0171 30.44% -0.0066
Cash Flow Per Share
65.06% -0.0034 41.73% -0.0044 -437.14% -0.0098 -139.14% -0.0075
Operating Income Per Share
-26.62% 0.0076 -7.29% 0.0045 4.18% 0.0104 -35.72% 0.0049
Net Asset Per Share
7.72% -0.3752 2.84% -0.3211 -52.51% -0.4066 -160.18% -0.3305
Basic Earning Per Share
122.36% 0.0313 233.86% 0.0854 2.91% -0.14 15.5% -0.0638
Diluted  Earning Per Share
74.36% -0.0359 233.86% 0.0854 2.91% -0.14 15.5% -0.0638
Profitability
Gross Profit Ratio
2.24% 9.457% 4.46% 11.173% -16.75% 9.250% 13.12% 10.696%
Operating Profit Ratio
1560.61% 2031.243% 3799.29% 3557.569% 75.19% -139.068% 74.5% -96.169%
Net Profit Ratio
123.4% 326.882% 238.64% 1826.161% 8.46% -1396.767% -31.68% -1317.212%
Earning Before Tax Ratio
123.4% 326.882% 238.64% 1826.161% 8.46% -1396.767% -31.68% -1317.212%
ROA
122.54% 3.274% 234.78% 8.922% -3.11% -14.524% 5.23% -6.620%
Yield Quality
Operating Profit To Total Profits
-- 621.399% -- 194.811% -- -- -- --
Operating Cash To Total Revenue
32.77% -110.677% -70.11% -230.473% 33.74% -164.632% -8.21% -135.487%
Capital Structure
Debt Assets Ratio
-3.72% 71.665% -0.84% 65.727% 24.09% 74.437% 16.5% 66.283%
Debt Equity Ratio
-13.14% 252.926% -2.45% 191.776% 94.25% 291.187% 48.95% 196.588%
Current Assets To tatal Assets
-33.81% 1.358% -3.8% 1.945% -30.97% 2.052% -57.03% 2.022%
Non Current Assets To Total Assets
0.71% 98.642% 0.08% 98.055% 0.95% 97.948% 2.82% 97.978%
Current Liabilities To tatal Liabilities
-86.98% 9.980% -88.09% 9.343% 824.9% 76.656% 757.6% 78.423%
Non Current Liabilities To Total Liabilities
285.62% 90.020% 320.16% 90.657% -74.55% 23.344% -76.25% 21.577%
Solvency
Current Ratio
428.03% 0.1899 714.3% 0.3168 -93.99% 0.036 -95.7% 0.0389
Operating Profit To Current Liabilities
8700.53% 2.269 29219.05% 2.7433 97.72% -0.0264 98.15% -0.0094
Operrating Cash Flow To Current Liabilities
-295.86% -0.1236 -1238.97% -0.1777 93.92% -0.0312 92.15% -0.0133
Share Equity Without Minority Interest To Total Liabilities
3.59% -0.5495 1.74% -0.5107 -24.27% -0.57 -151.93% -0.5198
Operating Cash Flow To Total Liabilities
48.46% -0.0123 -59.53% -0.0166 43.75% -0.0239 32.65% -0.0104
Operating Profit To Total Liabilities
1219.73% 0.2264 3569.27% 0.2563 78.94% -0.0202 84.13% -0.0074
Operating Capacity
Current Assets Turnover(T)
9.08% 0.4668 16.79% 0.2367 27.28% 0.4279 8.47% 0.2026
Total Assets Turnover(T)
-25.99% 0.008 -6.61% 0.0047 10.65% 0.0108 -27.99% 0.0051
Growth Ability
Operating Revenue GR 3Y
-917.93% -40.045% -28.47% -34.030% -106.7% -3.934% -131.52% -26.488%
Gross Income GR 3Y
-5633.69% -39.668% -6.39% -18.212% -99.42% 0.717% -114.42% -17.118%
Operating Profit GR 3Y
209.54% 258.816% 218.96% 296.955% 4842.71% 83.613% 395.45% 93.100%
EBT GR 3Y
1297.56% 113.963% 367.67% 169.883% 132.96% 8.154% 172.35% 36.325%
Net Profit GR 3Y
1297.56% 113.963% 367.67% 169.883% 132.96% 8.154% 172.35% 36.325%
Net Profit Attributable To The Parent Company GR 3Y
940.67% 117.598% 376.83% 173.025% 146.42% 11.300% 171.51% 36.286%
Total Assets GR 3Y
35.84% -11.639% 32.61% -12.886% 22.29% -18.140% -12.21% -19.121%
Share Equity Without Minority Interest GR 3Y
-57.01% -632.910% -636.27% -2005.147% -110.81% -403.106% -101.16% -272.338%
Equity GR 3Y
24.27% -50.269% 21.37% -46.240% -17.96% -66.376% -14.49% -58.809%
Total Liabilities GR 3Y
-55.14% 27.526% -50.91% 28.775% 13.6% 61.354% -25.14% 58.622%
Basic Earning Per Share GR 3Y
942.58% 117.604% 376.2% 172.991% 146.4% 11.280% 171.65% 36.327%
Net Assets Per Share GR 3Y
-57.01% -632.909% -636.27% -2005.147% -110.81% -403.106% -101.16% -272.337%
Other Indicators
Currency Unit
HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Pilot Pharmaceutical and Biotechnology Co., Ltd. is a Hong Kong investment holding company mainly engaged in pharmaceutical and biotechnology business. The company operates through five major divisions. The genetic testing Services Division provides genetic testing services in China and Hong Kong. Bio-industry products division distributes bio-industry products in China. Beauty equipment and products Trading Division is engaged in the trade of beauty equipment and products in Hong Kong, China. The securities investment division engages in securities investment in Hong Kong, China and outside Hong Kong, China. The R & D division is engaged in the R & D and commercialization of oral insulin products.
CEO: Nian Jiang
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...